Evaluation of knowledge, attitude, and behaviour of ophthalmologists about adenoviral conjunctivitis transmission and treatment An online survey for Turkish ophthalmologists

dc.authoridSELVER, OZLEM BARUT/0000-0003-3333-3349
dc.authoridsahin, gozde/0000-0002-6989-4378
dc.authorscopusid57356888400
dc.authorscopusid24077472700
dc.authorscopusid23989747000
dc.authorwosidSELVER, OZLEM BARUT/N-5108-2019
dc.authorwosidSAHIN, GOZDE/U-3704-2017
dc.contributor.authorSahin Vural, Gozde
dc.contributor.authorBarut Selver, Ozlem
dc.contributor.authorPalamar, Melis
dc.date.accessioned2023-01-12T19:50:37Z
dc.date.available2023-01-12T19:50:37Z
dc.date.issued2022
dc.departmentN/A/Departmenten_US
dc.description.abstractPurpose To determine the prevalence of adenoviral conjunctivitis in Turkish ophthalmologists, to provide an overview of the treatment and prophylaxis of adenoviral conjunctivitis, and to analyze the data in the context of evidence-based treatment recommendations. Methods An online questionnaire consisting of 20 multiple-choice questions about the characteristics of the respondents, the individual adenoviral conjunctivitis history of the ophthalmologists, their practice's approaches, and prescription preferences were emailed to Turkish ophthalmologists. Results The survey was emailed to 500 ophthalmologists; 45% of them returned the questionnaire. According to the responses, the history of adenoviral conjunctivitis infections was positive in 46.7% (n: 120), recurrent attack prevalence was 16.2% in ophthalmologists. Lubricants (67.6%) are the most preferred first-line treatment options for adenoviral conjunctivitis, followed by povidone-iodine (59.6%), topical antibiotics (51.1%), topical antivirals (29.3%), topical corticosteroids (26.7%), and topical nonsteroidal anti-inflammatory agents (19.6%). A total of 98.2% preferred to dismiss infected patients. The preferred prophylaxis options were frequent hand washing/use of gloves (97.8%), disinfection of medical devices (95.1%), isolation of infected patients (79.1%), hand hygiene with gemicides (58.7%). The percentage of single-dose eye drop selection was 46.2. Conclusions The findings of this survey showed that most Turkish ophthalmologists generally follow international guidelines for the treatment of adenoviral conjunctivitis. The treatment algorithm is still controversial, so ophthalmologists should be aware of treatment guideline updates in line with evidence-based recommendations. Having sufficient knowledge of the basic characteristics of viruses is important to control the spread of the disease.en_US
dc.identifier.doi10.1007/s10792-022-02323-4
dc.identifier.endpage3228en_US
dc.identifier.issn0165-5701
dc.identifier.issn1573-2630
dc.identifier.issue10en_US
dc.identifier.pmid35546379en_US
dc.identifier.scopus2-s2.0-85129870767en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage3221en_US
dc.identifier.urihttps://doi.org/10.1007/s10792-022-02323-4
dc.identifier.urihttps://hdl.handle.net/11454/76136
dc.identifier.volume42en_US
dc.identifier.wosWOS:000793624200006en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.ispartofInternational Ophthalmologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAdenovirusen_US
dc.subjectConjunctivitisen_US
dc.subjectOphthalmologistsen_US
dc.subjectPrescribingen_US
dc.subjectSurveyen_US
dc.subjectEpidemic Keratoconjunctivitisen_US
dc.subjectClinical-Featuresen_US
dc.subjectArtificial Tearsen_US
dc.subjectPovidone-Iodineen_US
dc.subjectCyclosporineen_US
dc.subjectCorticosteroidsen_US
dc.subjectDiagnosisen_US
dc.subjectKeratitisen_US
dc.subjectTrialen_US
dc.titleEvaluation of knowledge, attitude, and behaviour of ophthalmologists about adenoviral conjunctivitis transmission and treatment An online survey for Turkish ophthalmologistsen_US
dc.typeArticleen_US

Dosyalar